Europol–EMCDDA Joint Report on a new psychoactive substance: 1-benzylpiperazine (BZP)

DSpace Repositorium (Manakin basiert)

Europol–EMCDDA Joint Report on a new psychoactive substance: 1-benzylpiperazine (BZP)

In accordance with Article 5 of Council Decision 2005/387/JHA on information exchange, risk assessment and control of new psychoactive substances

Europol; European Monitoring Centre for Drugs and Drug Addiction
Dateien:
Thumbnail
987. KB
PDF
Zitierfähiger Link (URI): http://hdl.handle.net/10900/87569
http://nbn-resolving.de/urn:nbn:de:bsz:21-dspace-875690
http://dx.doi.org/10.15496/publikation-28955
http://nbn-resolving.org/urn:nbn:de:bsz:21-dspace-875696
http://nbn-resolving.org/urn:nbn:de:bsz:21-dspace-875694
Dokumentart: Verschiedenartige Texte
Erscheinungsdatum: 2007
Sprache: Englisch
Fakultät: Kriminologisches Repository
Fachbereich: Kriminologie
DDC-Klassifikation: 360 - Soziale Probleme, Sozialdienste, Versicherungen
Schlagworte: Droge , Drogenmissbrauch , Europäische Union
Zur Langanzeige

Abstract:

In December 2006, after examining the available information collected on BZP (1-benzylpiperazine), the EMCDDA and Europol decided to launch a procedure for the production of a Joint Report. Pursuant to the findings of this report, the Council of the EU formally requested a risk assessment of the substance, which was submitted to control measures and criminal penalties throughout the European Union in March 2008.

Das Dokument erscheint in: